The principals of THE SAGE GROUP may own stock in the companies included in the research reports.
At the end of the fourth quarter 2016 we owned the following securities:
Abbott Laboratories, Inc.
Derma Sciences Inc
PAD is not just a leg problem. PAD is a marker for severe systemic atherosclerosis as evidenced by the high morbidity and mortality.
Research has shown that within 5 years approximately 50% will experience a cardiovascular event (defined as a heart attack or stroke) and 30% of these will be fatal.
This 5-year mortality rate is higher than that of breast cancer or coronary artery disease.
(Volume I and Volume II)